<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This case report we presented aims to report a-31-year-old man with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) who developed <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI) and also aims to discuss the possible mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that traditional risk factors alone do not cause <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> with SLE, and SLE-related factors influence the atherogenic process </plain></SENT>
<SENT sid="2" pm="."><plain>We found that although SLE patients with <z:hpo ids='HP_0011009'>acute</z:hpo> MI benefit from percutaneous coronary intervention (PCI) therapy, it is very important to choose the reasonable antithrombotic strategies in patients with SLE and APS undergoing PCI who require oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
</text></document>